Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Asset Utilization Ratio (2017 - 2025)

Lexaria Bioscience's Asset Utilization Ratio history spans 9 years, with the latest figure at 0.1 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 91.7% year-over-year to 0.1; the TTM value through Nov 2025 reached 0.1, up 91.7%, while the annual FY2025 figure was 0.11, 39.33% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.1 at Lexaria Bioscience, down from 0.13 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 3.36 in Q2 2023 and bottomed at 5.72 in Q1 2023.
  • The 5-year median for Asset Utilization Ratio is 0.12 (2025), against an average of 0.28.
  • The largest annual shift saw Asset Utilization Ratio surged 2283.54% in 2022 before it tumbled 375.48% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.54 in 2021, then tumbled by 90.79% to 0.05 in 2022, then soared by 264.85% to 0.18 in 2023, then tumbled by 70.49% to 0.05 in 2024, then skyrocketed by 91.7% to 0.1 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Asset Utilization Ratio are 0.1 (Q4 2025), 0.13 (Q3 2025), and 0.08 (Q2 2025).